Skip to nav Skip to content

The Tandem Meetings, Transplant & Cellular Therapy Meetings of ASTCT and CIMBTR will be held in World Center Marriott, Orlando, February 15-19, 2023.

Moffitt scientists are presenting advances in areas like cellular immunotherapy for relapsed or refractory (R/R) acute myeloid leukemia (AML), myelodysplastic syndromes (MDS), acute lymphoblastic leukemia (ALL), lymphoma, multiple myeloma (MM) and allogeneic HCT.

Featured abstracts:

  • Developing Contemporary Survivorship Clinic for Recipients of Hematopoietic Cell Transplantation: A Single Center Experience (Mohty/Liu et al., abstract #490). We report here our successful experience in launching a contemporary HCT Survivorship Clinic at Moffitt. This consultative clinic model is staffed by dedicated advanced practice professional under supervision of faculty with expertise in BMT survivorship. Our survivorship clinic focuses on surveillance of late effects and general cancer screenings after allogeneic and autologous HCT with plans to expand to a broader population receiving other cellular therapies later in 2023. 

If you are attending, we hope you'll stop by our booth #823 to learn more about Moffitt.

The largest transplant practice of its kind in the southeastern United States, Moffitt Cancer Center’s Blood and Marrow Transplant and Cellular Immunotherapy (BMT CI) Program provides patients with comprehensive diagnostic, donor matching, transplant as well as chimeric antigen receptor or CAR T cell therapy, other immunotherapy, and supportive care services in a single location.

If you'd like to refer a patient to Moffitt Cancer Center, complete our online form or contact a physician liaison for assistance. As part of our efforts to shorten referral times as much as possible, online referrals are typically responded to within 24 - 48 hours.